MK-677, also called Ibutamoren, is an investigational compound. Scientists study it because it may help increase growth hormone (GH) and insulin-like growth factor (IGF-1) in preclinical models. Some researchers are now exploring how MK-677 may affect testosterone levels.
This blog explains what MK-677 does, how it works, and what research says about its effects on testosterone.
Note: The FDA does not approve MK-677 for human use. It is only allowed for laboratory research.
What is MK-677?
MK-677 is a growth hormone secretagogue. This means it may help the body release more growth hormone. It may work by copying the action of ghrelin, a natural hormone that sends signals to the brain to release GH.
When growth hormone increases, IGF-1 levels increase in the body of the research model. IGF-1 is linked with muscle growth, better sleep, and improved recovery in research animals. MK-677 is taken orally in most research studies. This may make it different from other GH-stimulating compounds that require injections in research models.
What is Testosterone and Why Does it Matter?
Testosterone is controlled by the hypothalamic-pituitary gonadal (HPG) axis. This system may include the brain and reproductive glands in research subjects.
Two important hormones– LH (luteinizing hormone) and FSH (follicle-stimulating hormone)- help the body make testosterone in animal models.
How MK-677 Might Affect Testosterone in Research?
MK-677 does not directly increase testosterone. It does not attach to androgen receptors like anabolic steroids or SARMs. Instead, MK-677 raises growth hormone and IGF-1, which may have indirect effects on testosterone.
Some researchers think MK-677 may help maintain or even support testosterone levels by improving overall hormone balance. Others look at how it affects the HPG axis and whether it causes suppression.
Many studies show that MK-677 does not lower LH, FSH, or testosterone in research animals.
What Do Scientific Studies Say About MK-677 and Testosterone?
Several studies have looked at how MK-677 affects hormone levels:
- Mullur et al. (2021) studied MK-677 in animal models. They saw increased muscle and GH levels but no signs of testosterone suppression.
- Chapman et al. (1996) found that MK-677 increased GH and IGF-1 without lowering testosterone in adult men during a short-term study.
- Makimura et al. (2012) looked at long-term MK-677 use in preclinical models and found stable testosterone levels throughout the study.
These findings suggest that MK-677 does not suppress natural testosterone in most research settings.
How Does MK-677 Compare with Other Compounds?
MK-677 vs SARMs or Steroids
SARMs like RAD-140 or LGD-4033 and steroids often lower testosterone by stopping the body of research subjects from making its own. MK-677 works differently. It does not bind to androgen receptors, so it may have a lower chance of suppression.
MK-677 vs HGH Injections
HGH injections give the body of research subject extra growth hormone from the outside. MK-677 may help the body of preclinical model release its own GH, which supports natural hormone balance, including testosterone.
MK-677 in Post-Cycle Research
Some researchers explore MK-677 in PCT studies, where the goal is to bring back natural testosterone levels. MK-677 may support recovery by raising GH and IGF-1 without blocking the HPG axis.
Important Research Notes
- MK-677 is only for laboratory use.
- Researchers must check hormone levels, like LH, FSH, testosterone, and IGF-1, when testing MK-677.
- MK-677 is not approved by the FDA for use in humans, supplements, or over-the-counter sales.
Where to buy MK-677 online for research purposes?
PureRawz is a trusted supplier; you may buy MK-677 for laboratory research purposes only.
Each product includes a reference-grade Certificate of Analysis (COA). This verifies purity, identity, and concentration.
Legal Status and Research Guidelines
MK-677 is not approved for human or veterinary use. It is classified as an investigational chemical. Most countries allow their use only for scientific research. They are listed on the World Anti-Doping Agency (WADA) banned substance list for athletes.
FAQs
Can MK-677 lower testosterone like steroids?
Research suggests MK-677 does not suppress testosterone like steroids or SARMs.
Is MK-677 used in PCT research?
Some researchers include MK-677 in PCT models to study recovery support, but it is not approved for such use.
Does MK-677 affect LH and FSH?
Most research shows stable LH and FSH levels during MK-677 studies.
How should MK-677 be stored in labs?
It should be stored in a cool, dry place away from direct sunlight. Researchers must follow proper storage, labeling, and ethical guidelines while using these substances in labs.
Conclusion
MK-677 shows promise in raising growth hormone and IGF-1 in lab studies. It does not directly change testosterone, but may support hormone balance. Research so far shows no strong signs of testosterone suppression.
Still, more studies are needed to fully understand how it affects the HPG axis and long-term hormonal health in research models.
Disclaimer
This content is for learning only and not medical advice. These products are for research use only. Research should follow IRB or IACUC rules. Please double-check all information before buying. By ordering, you agree to our Terms and Conditions. If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co
ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY. They are not for veterinary or human usage.
References
- Mullur, R., et al. “Effects of growth hormone secretagogues: MK-677 in aging and muscle function.” Biomedicine & Pharmacotherapy 143 (2021): 112187.
- U.S. Food and Drug Administration. “Certain Bulk Drug Substances Used in Compounding May Present Significant Safety Risks.” (2023).
- Walker, R. F., et al. “Endocrine and metabolic effects of MK-677: a novel oral GH secretagogue.” Journal of Clinical Pharmacology 38.10 (1998): 930–937.
- Butler, A. A., et al. “Ghrelin and growth hormone secretagogues in metabolism: insights from genetically modified models.” Endocrine Reviews 25.3 (2004): 426–457.